Skysong Innovations’ Economic Impact in Arizona
Locally Invested, Globally Inspired
In all cases, however, it’s worth noting that however locally invested they remain, these companies’ missions extend far beyond Arizona’s borders. Take HealthTell, whose early detection of diseases through patients’ unique immunosignatures—analyzed via a single drop of blood—came out of a $30.7 million Defense Department grant to develop diagnostics capable of protecting U.S. military against bioterrorism.
Skysong Innovations' enterprises also include patenting and licensing discoveries that are only just getting their sea legs. Its resources have enabled nascent technologies—like Videssa Breast—to move from ASU’s lab room to Provista Diagnostics’ boardroom to hospital exam rooms, where Professors Karen Anderson and Joshua LaBaer’s groundbreaking blood test can improve early breast cancer detection and augment the accuracy of abnormal or unclear mammograms.